Roanoke Times Copyright (c) 1995, Landmark Communications, Inc. DATE: THURSDAY, March 28, 1991 TAG: 9103280128 SECTION: NATIONAL/INTERNATIONAL PAGE: A-4 EDITION: METRO SOURCE: DATELINE: NEW YORK LENGTH: Short
The result emphasizes the need to link treatment to effective counseling for reducing transmission of the virus, the study authors said.
The work is presented in today's issue of the British journal Nature.
Researchers noted that the drug AZT, also called zidovudine, is used to delay the appearance of AIDS in persons infected with HIV-1, which causes acquired immune deficiency syndrome.
The reason such treatment could raise community death rates is that it gives infected people more time to infect others, the researchers said.
They found that an increase in AIDS death rates was possible if infected people tended to infect few others and few infected people were treated. - Associated Press
by CNB